Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Henrik Albrektsson"'
Autor:
Sunna Gunnarsdottir, Henrik Albrektsson, Julia Frydebo, Nicolae Miron, Jenny M. Kindblom, Ketil Størdal, Karl Mårild
Publikováno v:
Scandinavian Journal of Gastroenterology. 57:912-920
Objectives Celiac disease (CD) is a common yet largely underdiagnosed disease. This study aimed to test the feasibility of incorporating a non-targeted CD screening in a pediatric outpatient setting and evaluate its short-term impact on children with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::388f3dec9c470341899e6e1f63a8d7ec
https://doi.org/10.1080/00365521.2022.2050292
https://doi.org/10.1080/00365521.2022.2050292
Autor:
Jarl Hellman, Sofia Dahlqvist, Jan Bolinder, Tim Heise, Marcus Lind, Henrik Albrektsson, Magnus Wijkman, Aldina Pivodic, Irl B. Hirsch, Erik Schwarcz, William H. Polonsky, Arndís F. Ólafsdóttir
Publikováno v:
Diabetes Care. 44:141-149
OBJECTIVE Continuous glucose monitoring (CGM) reduces HbA1c and time spent in hypoglycemia in people with type 1 diabetes (T1D) treated with multiple daily insulin injections (MDI) when evaluated over shorter time periods. It is unclear to what exten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4f40324d8c33df629637ed30f9983c6
https://doi.org/10.2337/dc20-1468
https://doi.org/10.2337/dc20-1468
Autor:
Maria Ulnes, Henrik Albrektsson, Ketil Størdal, Robert Saalman, Jonas F. Ludvigsson, Karl Mårild
Aim To examine the clinical follow up of paediatric coeliac disease and the rate of loss of follow up during childhood, for which data are scarce. Methods In a cohort of coeliac children diagnosed in 2013–2018 in Gothenburg, Sweden, we retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35842217e204c345e2628282cde55ec0
http://hdl.handle.net/10852/99742
http://hdl.handle.net/10852/99742
Autor:
Ann-Marie Svensson, Henrik Albrektsson, Magnus Ekelund, Solveig Dahlqvist, Sara Hallström, Marcus Lind, Sheyda Sofizadeh, Irl B. Hirsch
Publikováno v:
Diabetes technologytherapeutics. 23(6)
Background: Although guidelines advocate similar continuous glucose monitoring (CGM) targets for insulin-treated persons with type 1 diabetes (T1D) and type 2 diabetes (T2D), it is unclear how thes...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2ef853b2d372f19ab34e868dc6ece7
https://pubmed.ncbi.nlm.nih.gov/33416422
https://pubmed.ncbi.nlm.nih.gov/33416422
Autor:
Marcus, Lind, Arndís F, Ólafsdóttir, Irl B, Hirsch, Jan, Bolinder, Sofia, Dahlqvist, Aldina, Pivodic, Jarl, Hellman, Magnus, Wijkman, Erik, Schwarcz, Henrik, Albrektsson, Tim, Heise, William, Polonsky
Publikováno v:
Diabetes care. 44(1)
Continuous glucose monitoring (CGM) reduces HbAThe GOLD trial was a randomized crossover trial performed over 16 months of CGM treatment in people with T1D treated with MDI. People completing the trial (The primary end point of the change in HbAThe S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a1df6f426605f667c84d225caf29b21
https://pubmed.ncbi.nlm.nih.gov/33199470
https://pubmed.ncbi.nlm.nih.gov/33199470
Autor:
Henrik Albrektsson, Marcus Lind, Tim Heise, Magnus Wijkman, Jarl Hellman, Aldina Pivodic, Erik Schwarcz, Jan Bolinder, William H. Polonsky, Irl B. Hirsch, Sofia Dahlqvist, Arndís F. Ólafsdóttir
Publikováno v:
Diabetes. 69
CGM reduces A1c and time in hypoglycemia in persons with T1D treated with MDI evaluated over short time periods. It’s unclear to what extent CGM improves glucose control, treatment satisfaction, hypoglycemia fear and diabetes-related QoL long term.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa01ad446ee68fb6a6fa1c302c3a7137
https://doi.org/10.2337/db20-64-or
https://doi.org/10.2337/db20-64-or
Autor:
Klara Westman, Henrik Imberg, Sofia Dahlqvist, Jaakko Tuomilehto, Irl B. Hirsch, Marcus Lind, Henrik Albrektsson
Publikováno v:
Primary care diabetes. 15(3)
From the MDI-liraglutide study, we evaluated variables associated with endogenous insulin production in persons with multiple daily insulin injections-treated type 2 diabetes by relating C-peptide, proinsulin and proinsulin/C-peptide ratio at baselin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274ccbd9628f4bbeb2b7d8efc82309c0
https://pubmed.ncbi.nlm.nih.gov/33303380
https://pubmed.ncbi.nlm.nih.gov/33303380